INPP4B57 and ATP6V0A458 are known modulators of osteoclast differentiation and have a prognostic locus for human osteoporosis, while SCARA3 is known to regulate the switch between adipocyte and osteoblast differentiation and thus represents a potential therapeutic target for bone loss and osteoporosis59. This evidence concerns the gene SCARA3 and osteoporosis.